$ARDX insider trading
Over the last 12 months, Ardelyx insiders reported 1 buy totaling $1.9M and 29 sales totaling $3.5M across SEC Form 4 filings. 23% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $1.9M 1 event
- Sold · 12m
- $3.5M 29 events
- Events · 12m
- 30 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 23% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Hohenleitner SusanChief Financial Officer · O | ▼ Sale | 1,558 | $3.86 | $6K | -0.7% | — |
| Aug 21, 2026 | Reilly Joseph JamesSee Remarks · O | ▼ Sale | 3,982 | $3.86 | $15K | -2.7% | 2 tranches |
| Aug 21, 2026 | Bishop John ESee Remarks · O | ▼ Sale | 19,750 | $3.86 | $76K | -5.9% | 2 tranches |
| Aug 21, 2026 | Brady James ParkerChief Human Resources Officer · O | ▼ Sale | 15,136 | $3.86 | $58K | -5.8% | 2 tranches |
| Aug 21, 2026 | Foster Eric DuaneChief Commercial Officer · O | ▼ Sale | 8,562 | $3.86 | $33K | -2% | 3 tranches |
| Aug 21, 2026 | Kelliher MikeChief Business Officer · O | ▼ Sale | 7,758 | $3.86 | $30K | -2.2% | 3 tranches |
| Aug 21, 2026 | Williams Laura AChief Patient Officer · O | ▼ Sale | 10,739 | $3.86 | $41K | -2.8% | 4 tranches |
| Aug 21, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 58,574 | $3.86 | $226K | -3.5% | 4 tranches |
| Jul 15, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 41,668 | $5.06 | $211K | -2.4% | plan |
| Jun 18, 2026 | Williams Laura AChief Patient Officer · O | ▼ Sale | 81,898 | $5.99 | $490K | -17.8% | plan |
| Jun 15, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 41,666 | $5.67 | $236K | -2.4% | plan |
| Apr 15, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 41,668 | $6.29 | $262K | -2.3% | plan |
| Mar 16, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 41,666 | $5.84 | $243K | -2.2% | plan |
| Feb 24, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 41,666 | $6.26 | $261K | -2.2% | plan |
| Feb 20, 2026 | MOTT DAVID MD | ▲ Buy | 333,333 | $5.84 | $1.9M | +11.2% | — |
| Feb 20, 2026 | Bishop John ESee Remarks · O | ▼ Sale | 3,179 | $5.85 | $19K | -0.9% | 3 tranches |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks · O | ▼ Sale | 4,991 | $5.85 | $29K | -3.2% | 3 tranches |
| Feb 20, 2026 | Williams Laura ASee Remarks · O | ▼ Sale | 8,176 | $5.85 | $48K | -1.8% | 2 tranches |
| Feb 20, 2026 | Hohenleitner SusanChief Financial Officer · O | ▼ Sale | 2,033 | $5.85 | $12K | -0.9% | 2 tranches |
| Feb 20, 2026 | Brady James ParkerChief Human Resources Officer · O | ▼ Sale | 2,543 | $5.85 | $15K | -1% | 2 tranches |
| Feb 20, 2026 | Kelliher MikeSee Remarks · O | ▼ Sale | 9,595 | $5.85 | $56K | -2.6% | 3 tranches |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 45,982 | $5.85 | $269K | -2.4% | 5 tranches |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer · O | ▼ Sale | 10,439 | $5.85 | $61K | -2.4% | 4 tranches |
| Jan 8, 2026 | Williams Laura AChief Patient Officer · O | ▼ Sale | 50,000 | $6.98 | $349K | -12.1% | plan |
| Nov 21, 2025 | GRAMMER ELIZABETH ASee Remarks · O | ▼ Sale | 5,995 | $5.54 | $33K | -2% | — |
| Nov 21, 2025 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 46,887 | $5.54 | $260K | -3.1% | — |
| Nov 21, 2025 | Kelliher MikeSee Remarks · O | ▼ Sale | 5,560 | $5.54 | $31K | -2% | — |
| Nov 21, 2025 | Williams Laura AChief Patient Officer · O | ▼ Sale | 6,426 | $5.54 | $36K | -1.8% | — |
| Nov 21, 2025 | Foster Eric DuaneChief Commercial Officer · O | ▼ Sale | 5,814 | $5.54 | $32K | -1.9% | — |
| Nov 21, 2025 | Reilly Joseph JamesSee Remarks · O | ▼ Sale | 11,086 | $5.54 | $61K | -9.2% | — |
| Aug 26, 2025 | Williams Laura AChief Patient Officer · O | ▼ Sale | 80,000 | $6.12 | $490K | -17.9% | plan · 2 tranches |
| Aug 21, 2025 | Kelliher MikeChief Business Officer · O | ▼ Sale | 5,417 | $5.93 | $32K | -1.9% | late |
| Aug 21, 2025 | Williams Laura AChief Patient Officer · O | ▼ Sale | 6,261 | $5.93 | $37K | -1.6% | — |
| Aug 21, 2025 | Renz Justin AChief Financial Officer · O | ▼ Sale | 7,037 | $5.93 | $42K | -1.7% | — |
| Aug 21, 2025 | RAAB MICHAELPresident & CEO · O·D | ▼ Sale | 45,687 | $5.93 | $271K | -3% | — |
| Aug 21, 2025 | GRAMMER ELIZABETH ASee Remarks · O | ▼ Sale | 5,841 | $5.93 | $35K | -1.9% | — |
| Aug 21, 2025 | Foster Eric DuaneChief Commercial Officer · O | ▼ Sale | 15,308 | $5.93 | $91K | -4.8% | — |
Every $ARDX filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Ardelyx filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ARDX feed.